Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease
BACKGROUND: Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. However, repeat endoscopy to define extent and severity of inflammation is not practical. Fecal calprotectin (FC) is a biomarker that can be...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2015/852723 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556086444425216 |
|---|---|
| author | Brian Bressler Remo Panaccione Richard N Fedorak Ernest G Seidman |
| author_facet | Brian Bressler Remo Panaccione Richard N Fedorak Ernest G Seidman |
| author_sort | Brian Bressler |
| collection | DOAJ |
| description | BACKGROUND: Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. However, repeat endoscopy to define extent and severity of inflammation is not practical. Fecal calprotectin (FC) is a biomarker that can be used as a surrogate test to distinguish inflammatory from noninflammatory gastrointestinal disease. |
| format | Article |
| id | doaj-art-b24956e1d1154bf196d744d7f311e985 |
| institution | Kabale University |
| issn | 2291-2789 2291-2797 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology and Hepatology |
| spelling | doaj-art-b24956e1d1154bf196d744d7f311e9852025-02-03T05:46:30ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972015-01-0129736937210.1155/2015/852723Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel DiseaseBrian Bressler0Remo Panaccione1Richard N Fedorak2Ernest G Seidman3Department of Medicine, Division of Gastroenterology, St Paul’s Hospital, Vancouver, British Columbia, CanadaDepartment of Medicine, University of Calgary, Calgary, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, McGill University Health Centre, Montreal, Quebec, CanadaBACKGROUND: Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. However, repeat endoscopy to define extent and severity of inflammation is not practical. Fecal calprotectin (FC) is a biomarker that can be used as a surrogate test to distinguish inflammatory from noninflammatory gastrointestinal disease.http://dx.doi.org/10.1155/2015/852723 |
| spellingShingle | Brian Bressler Remo Panaccione Richard N Fedorak Ernest G Seidman Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease Canadian Journal of Gastroenterology and Hepatology |
| title | Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease |
| title_full | Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease |
| title_fullStr | Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease |
| title_full_unstemmed | Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease |
| title_short | Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease |
| title_sort | clinicians guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease |
| url | http://dx.doi.org/10.1155/2015/852723 |
| work_keys_str_mv | AT brianbressler cliniciansguidetotheuseoffecalcalprotectintoidentifyandmonitordiseaseactivityininflammatoryboweldisease AT remopanaccione cliniciansguidetotheuseoffecalcalprotectintoidentifyandmonitordiseaseactivityininflammatoryboweldisease AT richardnfedorak cliniciansguidetotheuseoffecalcalprotectintoidentifyandmonitordiseaseactivityininflammatoryboweldisease AT ernestgseidman cliniciansguidetotheuseoffecalcalprotectintoidentifyandmonitordiseaseactivityininflammatoryboweldisease |